Uterine/female genital sarcomas
Author:
- 1 April 2000
- journal article
- review article
- Published by Springer Nature in Current Treatment Options in Oncology
- Vol. 1 (2) , 161-168
Abstract
Choosing the best management of uterine and vulvo-vaginal sarcomas depends on careful histologic review of the pathologic specimen. Prognosis and treatment vary greatly depending on specific histology, grade, and tumor stage. The initial approach to sarcomas of the female genital tract, with the occasional exception of vulvo-vaginal rhabdomyosarcoma, is surgery. Adjuvant radiation decreases local recurrence rates for uterine sarcomas, but has not been clearly shown to improve overall survival. It is frequently used as adjuvant therapy for resected high-grade or margin-positive vulvo-vaginal sarcomas, and for endometrial stromal sarcomas. Adjuvant chemotherapy has not been demonstrated to improve survival in vulvo-vaginal sarcomas, with the exception of vulvo-vaginal rhabdomyosarcomas, nor has it been demonstrated to improve survival in uterine sarcomas. Chemotherapy may be used for recurrent or persistent disease. The choice of agent depends on the histologic type of sarcoma.Keywords
This publication has 40 references indexed in Scilit:
- Results of Primary and Adjuvant Radiotherapy in the Treatment of Mixed Müllerian Tumors of the Corpus UteriGynecologic Oncology, 1999
- Uterine Leiomyosarcoma and Endometrial Stromal Sarcoma: Lymph Node Metastases and Sites of RecurrenceGynecologic Oncology, 1993
- Resection of pulmonary metastases from uterine sarcomasGynecologic Oncology, 1992
- Mixed Mullerian tumours of the uterus - prognostic factors: a clinical and histopathologic study of 147 casesRadiotherapy and Oncology, 1990
- Carcinosarcoma (Malignant Mixed Mesodermal Tumor) of the UterusInternational Journal of Gynecological Pathology, 1990
- Phase II trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus (A Gynecologic Oncology Group Study)American Journal of Obstetrics and Gynecology, 1989
- Clinical Aspects of Postirradiation Sarcomas1JNCI: Journal of the National Cancer Institute, 1988
- High-dose doxorubicin infusion therapy for disseminated mixed mesodermal sarcoma of the uterusCancer, 1987
- Radiotherapy and/or chemotherapy as adjuvant treatment of uterine sarcomasGynecologic Oncology, 1985
- Combined Radical Surgery, Radiation Therapy and Chemotherapy in Infants with Vulvovaginal Embryonal RhabdomyosarcomaObstetrics & Gynecology, 1973